﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/astrazeneca-receives-cdsco-approval-to-launch-eculizumab-in-india-16674</loc><lastmod>2025-01-17T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/bajaj-healthcare-receives-exclusive-rights-for-manufacturing-distribution-sales-of-finished-formulation-of-magnesium-l-threonate-16675</loc><lastmod>2025-01-17T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/fda-issues-five-observations-to-jubilant-pharmovas-salisbury-facility-in-usa-16676</loc><lastmod>2025-01-17T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/sun-pharma-to-acquire-100-stake-in-antibe-therapeutics-16677</loc><lastmod>2025-01-17T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/abbvie-partners-with-simcere-zaiming-to-develop-novel-trispecific-antibody-candidate-in-multiple-myeloma-16678</loc><lastmod>2025-01-17T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>